2024

• Zhao, A., Denneny, E., Goos, T., Savas, R., Ahmed, A., Brereton, C., van Es, H., Jo, H., De Liperi, A., Duncan, M., Corte, T., et al (2024). Mortality surrogates in combined pulmonary fibrosis and emphysema. European Respiratory Journal, 63(4), 2300127. [More Information]
• Visser, S., Lawler, C., Fermoyle, C., Spencer, L., McAnulty, A., Alison, J., Webster, S., Troy, L., Jo, H., Hayen, A., Corte, T. (2024). The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respiratory Medicine, 232, 107748. [More Information]
• Mackintosh, J., Goh, N., Reynolds, P., Chapman, S., Mutsaers, S., Webster, S., Moodley, Y., Corte, T., Keir, G., Troy, L., Jo, H., et al (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology, 29(2), 105-135. [More Information]

2023

• Bell, J., Munoz, P., Raffan, F., Shah, K., Shaw, M., Taylor, N., Visser, S., Yozghatlian, V., Wong, K., Sivam, S., Dwyer, T., Cunich, M., Dentice, R., Jo, H., Lau, E., et al (2023). Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Internal Medicine Journal. [More Information]

2022

• Clynick, B., Corte, T., Jo, H., Stewart, I., Glaspole, I., Grainge, C., Maher, T., Navaratnam, V., Hubbard, R., Hopkins, P., Cooper, W., et al (2022). Biomarker signatures for progressive idiopathic pulmonary fibrosis. European Respiratory Journal, 59(3), 1-12. [More Information]
• Walsh, S., Mackintosh, J., Calandriello, L., Silva, M., Sverzellati, N., Larici, A., Humphries, S., Lynch, D., Jo, H., Glaspole, I., Cooper, W., et al (2022). Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. American Journal of Respiratory and Critical Care Medicine, 206(7), 883-891. [More Information]
• Gardiner, A., Volovets, A., Haber, P., Jo, H., Visser, S., Yozghatlian, V., Taylor, N., Nolan, S., Dentice, R., Malouf, M., Sivam, D., et al (2022). ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk? Journal of Cystic Fibrosis, 21(5), 881-884. [More Information]
• Bell, J., Sivam, S., Dentice, R., Dwyer, T., Jo, H., Lau, E., Munoz, P., Nolan, S., Taylor, N., Visser, S., Yozghatlian, V., Wong, K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87. [More Information]

2021

• Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Adelstein, S., Webster, S., Corte, T. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration, 100(9), 853-864. [More Information]
• Mackintosh, J., Glenn, L., Barnes, H., Dunn, E., Bancroft, S., Reddy, T., Teoh, A., Troy, L., Jo, H., Geis, M., Corte, T., et al (2021). Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology, 26(6), 612-615. [More Information]
• Jee, A., Sheehy, R., Hopkins, P., Corte, T., Grainge, C., Troy, L., Symons, K., Spencer, L., Reynolds, P., Chapman, S., Jo, H., Bleasel, J., Parker, M., et al (2021). Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology, 26(1), 23-51. [More Information]
• Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Webster, S., Adelstein, S., Corte, T. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine, 187, 106581. [More Information]
• McLean, A., Webster, S., Fry, M., Lau, E., Corte, P., Torzillo, P., Troy, L., Jo, H., Geis, M., Rhodes, J., Spencer, L., Corte, T., et al (2021). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology, 26(1), 80-86. [More Information]

2020

• Brereton, C., Jo, H. (2020). Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids. Breathe, 16(3), 1-4. [More Information]
• Moore, I., Wrobel, J., Rhodes, J., Lin, Q., Webster, S., Jo, H., Troy, L., Grainge, C., Glaspole, I., Corte, T. (2020). Australasian interstitial lung disease registry (AILDR): Objectives, design and rationale of a bi-national prospective database. BMC Pulmonary Medicine, 20(1), 257. [More Information]
• Teoh, A., Jo, H., Chambers, D., Symons, K., Walters, E., Goh, N., Glaspole, I., Cooper, W., Reynolds, P., Moodley, Y., Corte, T. (2020). Blood monocyte counts as a potential prognostic marker for IPF: Analysis from the Australian IPF registry. European Respiratory Journal, 55(4), 1901855. [More Information]
• Clynick, B., Jo, H., Corte, T., Glaspole, I., Grainge, C., Hopkins, P., Reynolds, P., Chapman, S., Haydn Walters, E., Zappala, C., Cooper, W., Mahar, A., et al (2020). Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis. European Respiratory Journal, 56(3), 1902058. [More Information]
• Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Jo, H., Harris, B., Lau, E., et al (2020). Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet Respiratory Medicine, 8(2), 171-181. [More Information]

2019

• Jo, H., Corte, T., Glaspole, I., Grainge, C., Hopkins, P., Moodley, Y., Chapman, S., Walters, E., Zappala, C., Allan, H., Cooper, W., Goh, N., et al (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine, 19(1), 1-7. [More Information]
• Jo, H., Glaspole, I., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Zappala, C., Allan, H., Grainge, C., Cooper, W., Corte, T., et al (2019). Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. Respirology, 24(4), 361-368. [More Information]

2018

• Jo, H., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Corte, T., et al (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. BMC Pulmonary Medicine, 18(1), 1-8. [More Information]

2017

• Jo, H., Glaspole, I., Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Cooper, W., Corte, T., et al (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal, 49(2), 1-11. [More Information]
• Jee, A., Jo, H., Corte, T. (2017). Hypersensitivity pneumonitis: A protean and challenging disease. Respirology, 22(8), 1489-1490. [More Information]
• Jo, H., Corte, T. (2017). Nintedanib for idiopathic pulmonary fibrosis in the Japanese population. Respirology, 22(4), 630-631. [More Information]
• Jo, H., Troy, L., Keir, G., Chambers, D., Holland, A., Goh, N., Wilsher, M., De Boer, S., Moodley, Y., Grainge, C., Corte, T., et al (2017). Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1436-1458. [More Information]

2016

• Jo, H., Glaspole, I., Levin, K., McCormack, S., Mahar, A., Cooper, W., Cameron, R., Ellis, S., Cottee, A., Troy, L., Torzillo, P., Corte, T., et al (2016). Clinical impact of the interstitial lung disease multidisciplinary service. Respirology, 21(8), 1438-1444. [More Information]
• Jo, H., Corte, T., Moodley, Y., Levin, K., Westall, G., Hopkins, P., Chambers, D., Glaspole, I. (2016). Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. BMC Pulmonary Medicine, 16(1), 1-6. [More Information]
• Jo, H., Randhawa, S., Corte, T., Moodley, Y. (2016). Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs and Aging, 33(5), 321-334. [More Information]
• Jo, H., Corte, T., Wort, S., Eves, N., Piper, A., Wainwright, C. (2016). Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease. Respirology, 21(3), 556-566. [More Information]